D-dimer levels decreased in severe allergic asthma and chronic urticaria patients with the omalizumab treatment

Abstract

In conclusion, mediators and cells classically involved in procoagulant and anticoagulant pathways together play a role in SPA and CU pathophysiology, where omalizumab has its effect.